Aon Expands Data Center Insurance to $2.5B and Unveils GLP-1 Study Showing 47% Fewer Hospitalizations
Aon expanded its Data Center Lifecycle Insurance Program by $1B to $2.5B capacity, covering construction, cyber and operational risks for AI and cloud infrastructure. Its GLP-1 study of 192,000 U.S. users found nine-point lower medical cost growth and 47% fewer female cardiovascular hospitalizations with 50% lower ovarian cancer incidence.
1. Aon Expands Data Center Lifecycle Insurance Program to $2.5 Billion
Aon has announced a $1 billion increase in capacity for its proprietary Data Center Lifecycle Insurance Program (DCLP), bringing total coverage to $2.5 billion. Launched in 2025, DCLP integrates construction all risks, Delay in Start-Up (DSU), operational property damage and business interruption, cyber liability and tech E&O into one coordinated solution. The expanded program now offers up to $400 million in cyber and tech E&O coverage, $100 million in third-party liability (excluding U.S. exposures) and $500 million for project cargo and transport. By combining risk engineering and analytics through Aon’s Global Risk Consulting team, clients can secure capacity at scale, reduce underwriting friction and streamline execution of data center projects from groundbreaking through steady-state operations.
2. Aon’s Multi-Year GLP-1 Study Highlights Cost Savings and Cancer Risk Reductions for Women
In its latest analysis of U.S. commercial health claims data covering 192,000 GLP-1 users from July 2022 to March 2025, Aon found sustained GLP-1 adherence delivers significant financial and clinical benefits. Employers saw medical cost growth six percentage points lower at 30 months for diabetes patients and nine percentage points lower for those with ≥80 percent adherence; weight-loss cohorts recorded cost growth reductions of three and seven percentage points at 18 months, respectively. Female GLP-1 users experienced a 47 percent reduction in hospitalizations for major adverse cardiovascular events, approximately 50 percent lower incidence of ovarian cancer and 14 percent lower incidence of breast cancer versus non-users. Aon projects U.S. healthcare cost growth of 9.5 percent in 2026, with prescription drugs accounting for roughly 30 percent of total spend and GLP-1 therapies constituting nearly 20 percent of pharmacy costs, underscoring the value of adherence support in workforce health strategies.